Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cytarabine (cytosar-u) (1 trial)
deferasirox (exjade) (1 trial)
Leukemia (Phase 1)
Leukemia, Lymphoid (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Trials (1 total)
Trial APIs (2 total)